Gadolinium MRI contrast agents in patients with severe renal insufficiency : are they safe?

Iodine contrast nephropathy is the third most common cause of hospital-acquired acute renal failure. With the increasing number of diagnostic and interventional procedures, gadolinium-based contrast agents (approved by the FDA in 1988) have been considered a safe, non-nephrotoxic alternative.Includes bibliographical reference